Cargando…
Room for Improvement in Conducting and Reporting Non-Inferiority Randomized Controlled Trials on Drugs: A Systematic Review
BACKGROUND: A non-inferiority (NI) trial is intended to show that the effect of a new treatment is not worse than the comparator. We conducted a review to identify how NI trials were conducted and reported, and whether the standard requirements from the guidelines were followed. METHODOLOGY AND PRIN...
Autores principales: | Wangge, Grace, Klungel, Olaf H., Roes, Kit C. B., de Boer, Anthonius, Hoes, Arno W., Knol, Mirjam J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2965079/ https://www.ncbi.nlm.nih.gov/pubmed/21048948 http://dx.doi.org/10.1371/journal.pone.0013550 |
Ejemplares similares
-
Challenges of defining a non-inferiority margin: a case study of non-inferiority randomized controlled trials of oral anti-thrombolytic agents for prophylaxis of venous thromboembolic events after orthopedic surgery
por: Wangge, Grace, et al.
Publicado: (2011) -
Phase IV non-inferiority trials and additional claims of benefit
por: Bernabe, Rosemarie DLC, et al.
Publicado: (2013) -
Regulatory Scientific Advice on Non-Inferiority Drug Trials
por: Wangge, Grace, et al.
Publicado: (2013) -
Methods of defining the non-inferiority margin in randomized, double-blind controlled trials: a systematic review
por: Althunian, Turki A., et al.
Publicado: (2017) -
Quality of reporting of drug exposure in pharmacoepidemiological studies
por: Hempenius, Mirjam, et al.
Publicado: (2020)